Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Injecting Hope: TCS Debuts a People-Centric Solution for COVID-19 Testing and Vaccine Management

Posted On: 2021-03-03 21:52:17 (Time Zone: Arizona, USA)


Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has announced the launch of the TCS COVID-19 Testing and Vaccine Management Suite. This suite of modular, easy-to-deploy solutions streamlines every stage of the end-to-end testing and vaccination journeys, enabling more individuals to get tested and vaccinated faster and return to normal life experiences.

Behind every vaccination or test for COVID-19 isthe highly complex orchestration of multiple stakeholders - from manufacturing to transportation, allocation to storage, distribution to scheduling, and reporting to monitoring. There is an opportunity to provide a seamless process across the entire value chain to prevent issues that could slow down testing and vaccinations.

In designing its new solution suite, TCS emulated the example of successful retailers and other consumercentric enterprises and adopted their proven, people-centric approach to optimizing the testing and vaccination ecosystems. Further, given the urgency of the problem, re-purposing proven use cases from other consumer-facing industries helped speed up the design of an end-to-end solution.

"The pandemic is changing our world in many ways, driving stakeholder collaboration across industries that share a commitment to getting testing and vaccines to everyone," said Debashis Ghosh, Business Group Head - Life Sciences, Healthcare and Public Sector, TCS. "TCS' suite of COVID-19 Testing and Vaccine Management solutions is built to enable transparency, ease of access, and equity that will collectively accelerate a return to normalcy."

The TCS COVID-19 Testing and Vaccine Management Suite leverages AI, robotics, blockchain and the Internet of Things (IoT), as well as TCS' extensive network of leading technology partners. This suite transforms all five stages of the testing and vaccination journeys: research & manufacture, allocate & transport, store & distribute, schedule & administer, and monitor & re-open. It enables ecosystem participants at each of these stages to seamlessly share critical information among themselves while complying with privacy and consent regulations, and to scale up their operations so communities receive the required quantities of tests and vaccines. The suite includes the following key capabilities:

Research & Manufacture: A drug development platform for life sciences companies that provides faster access to new vaccines. The platform is powered by TCS' cognitive AI engine, data driven smart analytics and IoT to make clinical trials more agile and safe.

Allocate & Transport: Ensures secure transfer of controlled pharmaceuticals with real-time track and trace, and temperature monitoring through IoT and blockchain technology that integrates with ERP systems, and machine learning to monitor and optimize vaccine shipments.

Store & Distribute: Addresses challenges with the vaccine supply chain, including demand planning, supply visibility, and cold-storage handling. Enables digital ecosystems to provide faster access to vaccines.

Schedule & Administer: Improves customer engagement and provides transparency to vaccine administration and scheduling. Supports transportation coordination, contactless experiences, and patient surveys.

Monitor & Re-open: Offers an interoperable analytics platform that provides a view of patients and their vaccinations. In addition, the platform facilitates seamless travel, public gatherings, and safe office environments via secure orchestration of mandatory testing and inoculation data across stakeholders.

The COVID-19 Testing and Vaccine Management Suite is powered by TCS PACE™, which brings together the best of TCS' innovation assets and practices.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.3058.65 as compared to the previous close of Rs. 3010.55. The total number of shares traded during the day was 206125 in over 13362 trades.

The stock hit an intraday high of Rs. 3063.45 and intraday low of 2996.5. The net turnover during the day was Rs. 626159215.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

IIFL Securities Limited to acquire Category II AIF from IIFL Wealth Management Ltd

HDFC Bank Limited to raise up to Rs. 50,000 crore

Indo Asian Finance Ltd to consider allotment of 60 lakh shares on April 20, 2021

KEC International Limited Resumption of WKTL Transmission Project

IIFL Wealth Management Ltd to sell AIF Category-II business to IIFL Management Services Ltd

International Travel House Ltd Q4FY21 loss at Rs. 6.70 crore

Gujarat Hotels Ltd Q4FY21 net profit slides YoY, QoQ

ICICI Lombard General Insurance Company Limited board recommends final dividend of Rs. 4

Gujarat Hotels Ltd board recommends dividend of Rs. 1.80 for FY21

ICICI Lombard General Insurance Company Ltd reports Rs. 345.68 crore PAT in Q4FY21

HDFC Bank Ltd's gross NPAs at 1.32%, reduces QoQ

HDB Financial Services Ltd's gross NPAs at 3.9% as of March 31, 2021

HDFC Securities Ltd reports PAT of Rs. 253.1 crore in Q4FY21

Career Point signed MOU with Ministry of Social Justice and Empowerment for tutorial services

HDFC Bank's balance sheet increases 14.1% YoY

Indiamart arm to acquire 22% in Truckhall Pvt Ltd

HDFC Bank Ltd Q4FY21 consolidated net profit slips QoQ to Rs. 8433.78 crore

CRISIL downgrades rating of PVR Ltd

Hatsun Agro Product Ltd board to consider FY21 results on April 27, 2021

Choice International Limited allots 34,49,989 Equity Shares on Conversion of Warrants

Adani Renewable Energy Holding Fifteen Ltd receives 159 MWac solar power project

Coforge Limited board approves issue of NCDs for Rs. 340 crore

Glenmark Life Sciences Ltd files DRHP with SEBI for IPO

KDDL Limited extends rights issue closure date to May 3, 2021

SG Shinagawa Refractories India Private Limited commences commercial operation

Prestige Estates Projects Limited acquires stake in companies having land bank in North Bangalore

ABB Power Products and Systems India Ltd board to announce Q1CY2021 results on May 5, 2021

GE Power India Limited signs SPA with GE Power Systems GmbH

Carborundum Universal Ltd board to approve final dividend and FY21 results on April 28, 2021

PNB Housing Finance Ltd board to consider FY21 results, dividend and NCD issue on April 27, 2021

ESAF Small Finance Bank raises Rs 162 Cr through preferential allotment

Everything Summer - Bahamas launches new Spring Summer collection 2021

MCX and Nihilent Technologies partners with Times OOH

44 meritorious students benefit from Vedanta's Utkarsh Scholarship awarded in presence of Goa CM

Robot-Assisted Cancer Surgery Unit Launched in Apollo Proton Cancer Centre

IndiGo is the leader in COVID vaccine distribution in the country over the last three months

Peter England launches 'The Antiviral* Linen Project' with new brand campaign 'Easy On You'

Den Networks Ltd Q4FY21 consolidated PAT drops QoQ to Rs. 36.98 crore

Isgec Heavy Engineering, United Conveyor Corporation sign agreement

Mindtree Ltd posts consolidated of Rs. 317.3 crore in Q4FY21

Government of Ghana to takeover ownership of AirtelTigo Joint Venture

ICRA retains ratings of Nahar Industrial Enterprises Ltd

NTPC to issue Non-Convertible Bonds

CRISIL retains rating of NGL Fine-Chem Ltd

GTPL Hathway's Consolidated FY21 PAT at ₹ 1,885 million, up by 145%

DCB Bank Limited receives RBI nod for reappointment of Mr. Murali M. Natrajan as MD & CEO

Mindtree Ltd Board approves final dividend of Rs. 17.50

RITES consortium emerges L1 in Railway project in Bangladesh

Ashok Leyland Delivers Light Bullet Proof Vehicles to Indian Air Force in collaboration with Lockheed Martin

Maruti Suzuki India Ltd increases price of select models from April 16, 2021


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020